Details of the Drug Formulaction

General Information of Drug Formulation (ID: F10912)

Formulation Name
Ivacaftor 150 mg tablet
Company
Vertex Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Ivacaftor DMZC1HS Cystic fibrosis CA25 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Ammonia E00007 222 Alkalizing agent
Carmellose sodium E00625 Not Available Disintegrant
FD&C blue no. 2 E00446 2723854 Colorant
Ferrosoferric oxide E00231 14789 Colorant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 3350 E00652 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent